These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. Kim GH; Kellner CP; Hahn DK; Desantis BM; Musabbir M; Starke RM; Rynkowski M; Komotar RJ; Otten ML; Sciacca R; Schmidt JM; Mayer SA; Connolly ES J Neurosurg; 2008 Jul; 109(1):38-43. PubMed ID: 18593272 [TBL] [Abstract][Full Text] [Related]
3. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. McGirt MJ; Woodworth GF; Ali M; Than KD; Tamargo RJ; Clatterbuck RE J Neurosurg; 2007 Dec; 107(6):1080-5. PubMed ID: 18077943 [TBL] [Abstract][Full Text] [Related]
4. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications. Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369 [No Abstract] [Full Text] [Related]
5. The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage. Beadell NC; Thompson EM; Delashaw JB; Cetas JS J Neurosurg; 2012 Oct; 117(4):781-6. PubMed ID: 22920957 [TBL] [Abstract][Full Text] [Related]
6. Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage. Howington JU; Kutz SC; Wilding GE; Awasthi D J Neurosurg; 2003 Aug; 99(2):271-5. PubMed ID: 12924699 [TBL] [Abstract][Full Text] [Related]
7. Aneurysm location and clipping versus coiling for development of secondary normal-pressure hydrocephalus after aneurysmal subarachnoid hemorrhage: Japanese Stroke DataBank. Yamada S; Ishikawa M; Yamamoto K; Ino T; Kimura T; Kobayashi S; J Neurosurg; 2015 Dec; 123(6):1555-61. PubMed ID: 26230474 [TBL] [Abstract][Full Text] [Related]
11. Relationship between intracranial pressure and other clinical variables in patients with aneurysmal subarachnoid hemorrhage. Heuer GG; Smith MJ; Elliott JP; Winn HR; LeRoux PD J Neurosurg; 2004 Sep; 101(3):408-16. PubMed ID: 15352597 [TBL] [Abstract][Full Text] [Related]
12. Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. Mocco J; Mack WJ; Kim GH; Lozier AP; Laufer I; Kreiter KT; Sciacca RR; Solomon RA; Mayer SA; Connolly ES J Neurosurg; 2002 Sep; 97(3):537-41. PubMed ID: 12296636 [TBL] [Abstract][Full Text] [Related]
13. Incidence of Terson's syndrome in patients with SAH in a Chinese hospital. Wu LN; He T; Xing YQ; Shen Y Curr Eye Res; 2013 Jan; 38(1):97-101. PubMed ID: 22913767 [TBL] [Abstract][Full Text] [Related]
14. Blood pressure changes after aneurysmal subarachnoid hemorrhage and their relationship to cerebral vasospasm and clinical outcome. Faust K; Horn P; Schneider UC; Vajkoczy P Clin Neurol Neurosurg; 2014 Oct; 125():36-40. PubMed ID: 25083804 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms. Kao HW; Lee KW; Kuo CL; Huang CS; Tseng WM; Liu CS; Lin CP PLoS One; 2015; 10(7):e0132115. PubMed ID: 26176774 [TBL] [Abstract][Full Text] [Related]